OMass Therapeutics Overview

  • Founded
  • 2016
Founded
  • Status
  • Private
  • Employees
  • 31
Employees
  • Latest Deal Type
  • Early Stage VC
  • Latest Deal Amount
  • $3.87M
Latest Deal Amount
  • Investors
  • 4

OMass Therapeutics General Information

Description

Developer of a structural mass spectrometry technology platform intended to discover novel medicines. The company's platform offers access to native mass spectrometry without having to establish sophisticated instrumentation and expertise in-house, as well as provides a way to study complex protein assemblies and their interactions with other biological molecules, enabling biotechnology and pharmaceutical clients to tackle challenging drug targets and biotherapeutics, within a dynamic and collaborative framework.

Contact Information

Website
Formerly Known As
OMass Technologies
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Drug Discovery
Other Industries
Discovery Tools (Healthcare)
Biotechnology
Primary Office
  • The Schrödinger Building
  • Heatley Road, The Oxford Science Park
  • Oxford OX4 4GE
  • England, United Kingdom
+44 01865 000000

OMass Therapeutics Timeline

2018201920202021
Financing RoundCaptured Employee CountEstimated Employee Growth
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

OMass Therapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Early Stage VC 21-Oct-2020 $3.87M 0000 000.00 Completed Generating Revenue
3. Early Stage VC (Series A) 13-Feb-2020 000.00 000.00 000.00 Completed Generating Revenue
2. Early Stage VC (Series A) 26-Jun-2018 $18.6M $21.7M 000.00 Completed Generating Revenue
1. Seed Round 29-Mar-2016 $3.07M $3.07M 00.000 Completed Startup
To view OMass Therapeutics’s complete valuation and funding history, request access »

OMass Therapeutics Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series A 00,000,000 00.000000 00.00 00.00 00 00.00 00.00
A Ordinary 0,000,000 00.000000 00.00 00.00 00 00.00 00.000
Ordinary 1,165,513 $0.001290 $1.29 $1.29 1x $1.29 8.03%
To view OMass Therapeutics’s complete cap table history, request access »

OMass Therapeutics Executive Team (7)

Name Title Board Seat Contact Info
Ali Jazayeri Ph.D Chief Scientific Officer
Hsin-Yung Yen Ph.D Co-Founder & Director of Biology
Idlir Liko Ph.D Co-Founder & Director of Technology
Jonathan Hopper Ph.D Co-Founder & Vice President, Platforms
Dame Robinson Co-Founder, Scientific Advisor & Board Member
You’re viewing 5 of 7 executive team members. Get the full list »

OMass Therapeutics Board Members (11)

Name Representing Role Since
Dame Robinson OMass Therapeutics Co-Founder, Scientific Advisor & Board Member 000 0000
Edward Hodgkin Ph.D Syncona Chairman 000 0000
Jonathan Montagu Self Board Member 000 0000
Lachlan MacKinnon Oxford Sciences Innovation Board Member 000 0000
Magdalena Jonikas Ph.D Syncona Board Member 000 0000
You’re viewing 5 of 11 board members. Get the full list »

OMass Therapeutics Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

OMass Therapeutics Investors (4)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Syncona Venture Capital Minority 000 0000 000000 0
University of Oxford Corporation Minority 000 0000 000000 0
Oxford Sciences Innovation Venture Capital Minority 000 0000 000000 0
Oxford Spin-out Equity Management Venture Capital Minority 000 0000 000000 0
To view OMass Therapeutics’s complete investors history, request access »

OMass Therapeutics Acquisitions (1)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
00000000000 000000 25-Feb-2020 000000000000000000 Biotechnology 00000000 000000
To view OMass Therapeutics’s complete acquisitions history, request access »